Back to Trades
Upadhyay Suketu
EVP & Chief Financial OfficerCIK 0001533149
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 11
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 3
- Active
- 2025–2026
Upadhyay Suketu, EVP & Chief Financial Officer, has filed 11 SEC reports (2025–2026), spread across 3 companies, totaling $5.5M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
11 loaded
| May 6 | INCY INCYTE CORP | Upadhyay Suketu | EVP & Chief Financial Officer | Other | $0 |
| May 6 | INCY INCYTE CORP | Upadhyay Suketu | EVP & Chief Financial Officer | Grant | $3.7M |
| May 5 | VRTX VERTEX PHARMACEUTICALS INC / MA | Upadhyay Suketu | Director | Award | $1.2M |
| Apr 17 | VRTX VERTEX PHARMACEUTICALS INC / MA | Upadhyay Suketu | Director | Award | $0 |
| Feb 27 | ZBH ZIMMER BIOMET HOLDINGS, INC. | Upadhyay Suketu | Insider | Exercise | $281.8K |
| Feb 24 | ZBH ZIMMER BIOMET HOLDINGS, INC. | Upadhyay Suketu | Insider | Exercise | $241.2K |
| Feb 23 | ZBH ZIMMER BIOMET HOLDINGS, INC. | Upadhyay Suketu | Insider | Award | $0 |
| Jan 20 | VRTX VERTEX PHARMACEUTICALS INC / MA | Upadhyay Suketu | Director | Award | $0 |
| Nov 3 | ZBH ZIMMER BIOMET HOLDINGS, INC. | Upadhyay Suketu | Insider | Award | $0 |
| Oct 17 | VRTX VERTEX PHARMACEUTICALS INC / MA | Upadhyay Suketu | Director | Award | $0 |
| Jul 17 | VRTX VERTEX PHARMACEUTICALS INC / MA | Upadhyay Suketu | Director | Award | $0 |
11 filings